The government of India has issued a registration certificate and permission to import Moderna’s Covid-19 vaccine for restricted emergency use in adults aged 18 years and older. Moderna has also been granted emergency, condition, interim, or provisional authorisation for its Covid-19 vaccine by health agencies from more than 50 countries and is part of the World Health Organization’s emergency use listing.
Direct Biologics, a science-based manufacturer of regenerative biologic products, announced that the US Food and Drug Administration (FDA) has approved its application for a Phase I/II trial of ExoFlo in treating mild to moderate Covid-19 under an investigational new drug (IND) protocol. This is the company’s third FDA-approved IND clinical trial, and also signifies the first FDA-approved IND that examines the use of extracellular vesicles for treating mild to moderate Covid-19.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Russian Direct Investment Fund (RDIF) has announced positive results from the UAE Ministry of Health’s safety and efficacy data on the Russian Sputnik V Covid-19 vaccine. The vaccine was found to be 97.8% effective against the SARS-CoV-2 virus, while 100% effective against severe Covid-19 cases. The UAE had authorised the emergency use of the Russian vaccine in January 2021.
